» Authors » Sebastien Sanges

Sebastien Sanges

Explore the profile of Sebastien Sanges including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 44
Citations 257
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Le Maitre M, Guerrier T, Sanges S, Chepy A, Collet A, Launay D
Autoimmun Rev . 2025 Feb; 24(5):103782. PMID: 40010623
B cells play a key role in the pathophysiology of systemic sclerosis (SSc). While they are less characterized than their circulating counterparts, tissue-infiltrating B cells may have a more direct...
2.
Lefevre G, Bleuse S, Puyade M, Moulis G, Neel A, Abisror N, et al.
Allergy . 2025 Jan; PMID: 39757773
Background: Hypereosinophilic syndromes (HES) are a heterogenous group of eosinophilic disorders. To date, only retrospective studies of limited sample-size and/or follow-up duration are available. Methods: The COHESion study is a...
3.
Gachet B, Jouvray M, Koether V, Collet A, Morell-Dubois S, Sanges S, et al.
J Scleroderma Relat Disord . 2024 Nov; 9(3):203-209. PMID: 39493735
Background: Anemia is considered a risk factor of severity in systemic sclerosis. Yet, limited data are available on the frequency and causes of anemia in systemic sclerosis. The objectives of...
4.
Collet A, de Chambure D, Moitrot E, Breyne G, Mirgot F, Rogeau S, et al.
Clin Rev Allergy Immunol . 2024 Oct; 67(1-3):47-57. PMID: 39436576
The presence of IgG anti-IgA in the serum of primary immunodeficiency (PID) patients has long been considered responsible for hypersensitivity (HS) to immunoglobulin preparations (IgPs), but this link is increasingly...
5.
Farhat M, Guerreschi P, Morell-Dubois S, Deken V, Labreuche J, Sanges S, et al.
J Scleroderma Relat Disord . 2024 Jun; 9(2):124-133. PMID: 38910601
Background: Systemic sclerosis is a fibrotic disease. Body image assessments could be key in optimizing care; however, data are scarce. The main objective was to assess the perception of aesthetic...
6.
Martel M, Leurs A, Launay D, Behal H, Chepy A, Collet A, et al.
Autoimmun Rev . 2024 Mar; 23(5):103536. PMID: 38555075
Objectives: Estimate the global prevalence of anti-Ro52-kDa/SSA (TRIM21) autoantibodies in systemic sclerosis (SSc), and describe the associated clinical phenotype, through a systematic review and meta-analysis of published reports and new...
7.
Sanges S, Tian W, Dubucquoi S, Chang J, Collet A, Launay D, et al.
Eur Respir J . 2024 Mar; 63(4). PMID: 38485150
There is an unmet need for new therapeutic strategies that target alternative pathways to improve the prognosis of patients with pulmonary arterial hypertension (PAH). As immunity has been involved in...
8.
Astouati Q, Machet T, Houssais C, Noury J, Allenbach Y, Gallay L, et al.
Rheumatology (Oxford) . 2024 Mar; 64(3):1431-1436. PMID: 38430004
Objectives: To describe the characteristics of patients with Sjögren's disease (SjD) and inclusion-body myositis (IBM), and how they compare to SjD patients with other inflammatory myopathies (IM). Methods: Patients were...
9.
Collet A, Sanges S, Ghulam A, Genin M, Soudan B, Sobanski V, et al.
Rheumatology (Oxford) . 2023 Dec; 64(1):283-295. PMID: 38141209
Objective: The renin-angiotensin-aldosterone system (RAAS) and glucocorticoids (GCs) are involved in vascular remodeling and fibrosis but have not been extensively studied in systemic sclerosis (SSc). Our aim was to investigate...
10.
Speca S, Farhat M, Jendoubi M, Guerrier T, Sanges S, Staumont-Salle D, et al.
Sci Rep . 2023 Sep; 13(1):15102. PMID: 37700078
Systemic sclerosis (SSc) is the most severe systemic autoimmune disease with currently no cure. Intravenous immunoglobulins (IVIg) are an attractive candidate in this disease to counteract inflammation and fibrosis but...